欢迎使用我们的服务!
限时优惠,立即购买享受折扣
24小时客服在线,随时为您服务
优质产品,值得信赖

NICE recommends MSD’s pembrolizumab for locally advanced cervical cancer

NICE recommends MSD’s pembrolizumab for locally advanced cervical cancer

First immunotherapy approved for LACC in England offers new treatment option for women